MedTrace Logo

Neuromuscular Electrical Stimulation in Acute Ischemic Stroke

NCT03653312 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-06-25

No results posted yet for this study

Summary

The purpose of the study is to examine the added effect of NeuroMuscular Electric Stimulation (NMES) in addition to exercise therapy in the acute phase of ischemic stroke.

This randomized controlled trial includes 50 patients allocated to either control or intervention.

The inclusion, test, training and re-test will be provided during the first 14 days after ictus, starting day 1 or 2 after ictus and a follow-up at day 90.

The exercise training with external NMES is done with the patient every weekday for 12 minutes.

Conditions

Interventions

DEVICE

NMES

Neuromuscular electrical stimulation of the paretic lower limb during exercise

Sponsors & Collaborators

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Troels Wienecke, MD, PhD · Department of Neurology, Zealand University Hospital, University of Copenhagen, Roskilde, Denmark

  • Henriette Busk, PT · Dept. of Neurology, Zealand University Hospital, and Department of Physiotherapy and Occupational Therapy, Naestved-Slagelse-Ringsted Hospital, Copenhagen University

  • Søren T Skou, PT, PhD · University of Southern Denmark and Naestved-Slagelse-Ringsted Hospitals

  • Gert Kwakkel · Dept. Rehabilitation Medicine, VU University Medical Center, Amsterdam, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-27
Primary Completion
2020-06-03
Completion
2020-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03653312 on ClinicalTrials.gov